Presentation References:
Allsop D, Lintzeris N, Copeland J, Dunlop A, McGregor I (2015) Cannabinoid replacement
therapy (CRT): nabiximols (Sativex) as a novel treatment for cannabis withdrawal. Clin
Pharmacol Ther 97:571–574. https://doi.org/10.1002/cpt.109
• Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid
analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014
Oct;174(10):1668-73. 10.1001/jamainternmed.2014.4005
• Balter RE, Cooper ZD, Haney M (2014) Novel pharmacologic approaches to treating
cannabis use disorder. Curr Addict Rep 1:137–143. https://www.researchgate.net/profile/Margaret_Haney/publication/262573000_Novel_Pharmacologic_Approaches_to_Treating_Cannabis_Use_Disorder/links/54242cc30cf238c6ea6e974b/Novel-Pharmacologic-Approaches-to-Treating-Cannabis-Use-Disorder.pdf
• Bradford AC, Bradford WD: Medical marijuana laws reduce prescription medication use
in Medicare Part D. Health Affairs 2016; 35:1230–1236
• Brezing CA, Levin FR (2018) The current state of pharmacological treatments for
cannabis use disorder and withdrawal. Neuropsychopharmacology 43:173– 194. https://doi.org/10.1038/npp.2017.212
• Hartung B, Kauferstein S, Ritz-Timme S, Daldrup T. Sudden unexpected death under
acute influence of cannabis. Forensic Sci Int. 2014 Apr;237:e11-3.
• Hurd, Y. L., Spriggs, S., Alishayev, J., Winkel, G., Gurgov, K., Kudrich, C., . . . Salsitz, E.
(2019). Cannabidiol for the reduction of cue-induced craving and anxiety in drug- abstinent individuals with heroin use disorder: A double-blind randomized placebo- controlled trial. American Journal of Psychiatry, 2019 Nov 1;176(11):911-922.
• Olfson, M., Wall, M. M., Liu, S. M., & Blanco, C. (2017). Cannabis use and risk of
prescription opioid use disorder in the United States. American Journal of Psychiatry,
175(1), 47-53.
Page, K., Murray-Krezan, C., Leeman, L. et al. Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy. Addict Sci Clin Pract 17, 3 (2022)
https://ascpjournal.biomedcentral.com/counter/pdf/10.1186/s13722-021-00285-z.pdf
• Volkow ND, Baler RD, Compton WM, Weiss SRB (2014) Adverse health effects of
marijuana use. N Engl J Med 370:2219–2227. https://doi.org/10.1056/NEJMra1402309
• Volkow ND, Swanson JM, Evins AE, DeLisi LE, Meier MH, Gonzalez R, Bloomfield MAP,
Curran HV, Baler R (2016) Effects of cannabis use on human behavior, including
cognition, motivation, and psychosis: a review. JAMA Psychiat 73:292– 297. https://doi.org/10.1001/jamapsychiatry.2015.3278
• Zehra, A., Burns, J., Liu, C.K. et al. Cannabis Addiction and the Brain: a Review. J
Neuroimmune Pharmacol 13, 438–452 (2018).
amotivational syndrome research:
https://link.springer.com/content/pdf/10.1007/s00213-021-06032-1.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732901/
https://link.springer.com/article/10.1007/s40473-023-00268-1
https://link.springer.com/article/10.1007/s11469-019-00132-y